eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | scleroderma |
| Symptom | C0206062|interstitial lung disease |
| Sentences | 8 |
| PubMedID- 21314931 | 46 scleroderma patients with evidence of interstitial lung disease on high resolution computed tomography (hrct) (reticular pattern and/or ground glass or honeycombing), consecutively admitted to the outpatient clinic of the rheumatology division of the catholic university in rome from january 2007 to december 2009, consenting to undergo bronchoalveolar lavage, have been included in the study. |
| PubMedID- 20352228 | To evaluate the role and the prognostic value of bronchoalveolar lavage (bal) in scleroderma patients with interstitial lung disease. |
| PubMedID- 22826062 | interstitial lung disease often coexists with scleroderma and is accompanied by functional lung abnormalities. |
| PubMedID- 24448503 | Objective: this study aimed to determine the relationship between main pulmonary artery diameter (mpad) and pulmonary hypertension (ph) in scleroderma patients with and without interstitial lung disease. |
| PubMedID- 21552414 | Long term effects of cyclophosphamide treatment on lung function and survival in scleroderma patients with interstitial lung disease. |
| PubMedID- 22402140 | This study aimed to evaluate vegf concentration in the bronchoalveolar lavage fluid (balf) of scleroderma patients with interstitial lung disease, to correlate the cytokine levels in plasma and in the lung with pulmonary functional, radiological and cellular parameters, and with the progression of lung disease. |
| PubMedID- 22723597 | Up-regulated expression of hla-drb5 transcripts and high frequency of the hla-drb5*01:05 allele in scleroderma patients with interstitial lung disease. |
| PubMedID- 25110305 | Good outcome of interstitial lung disease in patients with scleroderma associated to anti-pm/scl antibody. |
Page: 1